Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Assessment of genetic and non-genetic risk factors for venous thromboembolism in glioblastoma - The predictive significance of B blood group.

Heenkenda MK, Malmström A, Lysiak M, Mudaisi M, Bratthäll C, Milos P, Strandeus M, Åkesson L, Söderkvist P, Uppugunduri S, Osman A.

Thromb Res. 2019 Nov;183:136-142. doi: 10.1016/j.thromres.2019.10.009. Epub 2019 Oct 22.

PMID:
31677594
2.

Population-based study of risk of venous thromboembolism associated with various oral contraceptives.

Farmer RD, Lawrenson RA, Thompson CR, Kennedy JG, Hambleton IR.

Lancet. 1997 Jan 11;349(9045):83-8.

PMID:
8996419
3.

Predictors of Venous Thromboembolism in Patients with Glioblastoma.

Nabi S, Kahlon P, Bozorgnia F, Arshad A, Mikkelsen T, Donthireddy V.

Pathol Oncol Res. 2016 Apr;22(2):311-6. doi: 10.1007/s12253-015-0008-7. Epub 2015 Nov 7.

PMID:
26547860
4.

Recurrent venous thromboembolism in glioblastoma.

Edwin NC, Khoury MN, Sohal D, McCrae KR, Ahluwalia MS, Khorana AA.

Thromb Res. 2016 Jan;137:184-188. doi: 10.1016/j.thromres.2015.11.027. Epub 2015 Nov 22.

PMID:
26657302
5.

Venous thromboembolism in patients with glioblastoma multiforme: Findings of the RIETE registry.

Portillo J, de la Rocha IV, Font L, Braester A, Madridano O, Peromingo JA, Apollonio A, Pagán B, Bascuñana J, Monreal M; RIETE Investigations.

Thromb Res. 2015 Dec;136(6):1199-203. doi: 10.1016/j.thromres.2015.10.043. Epub 2015 Oct 30.

PMID:
26548619
6.

A prospective multicenter study of venous thromboembolism in patients with newly-diagnosed high-grade glioma: hazard rate and risk factors.

Streiff MB, Ye X, Kickler TS, Desideri S, Jani J, Fisher J, Grossman SA.

J Neurooncol. 2015 Sep;124(2):299-305. doi: 10.1007/s11060-015-1840-z. Epub 2015 Jun 23.

7.

Venous thromboembolism (VTE) and glioblastoma.

Yust-Katz S, Mandel JJ, Wu J, Yuan Y, Webre C, Pawar TA, Lhadha HS, Gilbert MR, Armstrong TS.

J Neurooncol. 2015 Aug;124(1):87-94. doi: 10.1007/s11060-015-1805-2. Epub 2015 May 19.

PMID:
25985958
8.

Risk factors and clinical impact of postoperative symptomatic venous thromboembolism.

Gangireddy C, Rectenwald JR, Upchurch GR, Wakefield TW, Khuri S, Henderson WG, Henke PK.

J Vasc Surg. 2007 Feb;45(2):335-341; discussion 341-2.

9.

ABO Blood Group Is a Predictor for the Development of Venous Thromboembolism After Total Joint Arthroplasty.

Newman JM, Abola MV, Macpherson A, Klika AK, Barsoum WK, Higuera CA.

J Arthroplasty. 2017 Sep;32(9S):S254-S258. doi: 10.1016/j.arth.2017.02.063. Epub 2017 Mar 2.

PMID:
28366316
10.

B blood group: A strong risk factor for venous thromboembolism recurrence.

Baudouy D, Moceri P, Chiche O, Bouvier P, Schouver ED, Cerboni P, Gibelin P, Ferrari E.

Thromb Res. 2015 Jul;136(1):107-11. doi: 10.1016/j.thromres.2015.05.002. Epub 2015 May 8.

PMID:
25981188
11.

ABO blood group, other risk factors and incidence of venous thromboembolism: the Longitudinal Investigation of Thromboembolism Etiology (LITE).

Ohira T, Cushman M, Tsai MY, Zhang Y, Heckbert SR, Zakai NA, Rosamond WD, Folsom AR.

J Thromb Haemost. 2007 Jul;5(7):1455-61. Epub 2007 Apr 9.

12.

Venous Thrombosis Risk after Cast Immobilization of the Lower Extremity: Derivation and Validation of a Clinical Prediction Score, L-TRiP(cast), in Three Population-Based Case-Control Studies.

Nemeth B, van Adrichem RA, van Hylckama Vlieg A, Bucciarelli P, Martinelli I, Baglin T, Rosendaal FR, le Cessie S, Cannegieter SC.

PLoS Med. 2015 Nov 10;12(11):e1001899; discussion e1001899. doi: 10.1371/journal.pmed.1001899. eCollection 2015 Nov.

13.

Neuromuscular electrical stimulation for the prevention of venous thromboembolism.

Hajibandeh S, Hajibandeh S, Antoniou GA, Scurr JR, Torella F.

Cochrane Database Syst Rev. 2017 Nov 21;11:CD011764. doi: 10.1002/14651858.CD011764.pub2. Review.

14.

Interventions for implementation of thromboprophylaxis in hospitalized patients at risk for venous thromboembolism.

Kahn SR, Morrison DR, Diendéré G, Piché A, Filion KB, Klil-Drori AJ, Douketis JD, Emed J, Roussin A, Tagalakis V, Morris M, Geerts W.

Cochrane Database Syst Rev. 2018 Apr 24;4:CD008201. doi: 10.1002/14651858.CD008201.pub3. Review.

15.

ABO blood groups and risk of venous thromboembolism during pregnancy and the puerperium. A population-based, nested case-control study.

Larsen TB, Johnsen SP, Gislum M, Møller CA, Larsen H, Sørensen HT.

J Thromb Haemost. 2005 Feb;3(2):300-4.

16.

Risk factors and pharmacologic prophylaxis for venous thromboembolism in elective spine surgery.

McLynn RP, Diaz-Collado PJ, Ottesen TD, Ondeck NT, Cui JJ, Bovonratwet P, Shultz BN, Grauer JN.

Spine J. 2018 Jun;18(6):970-978. doi: 10.1016/j.spinee.2017.10.013. Epub 2017 Oct 19.

PMID:
29056565
17.

Non-O blood type is the commonest genetic risk factor for VTE: results from a meta-analysis of the literature.

Dentali F, Sironi AP, Ageno W, Turato S, Bonfanti C, Frattini F, Crestani S, Franchini M.

Semin Thromb Hemost. 2012 Jul;38(5):535-48. doi: 10.1055/s-0032-1315758. Epub 2012 Jun 27. Review.

PMID:
22740183
18.

Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy.

Di Nisio M, Porreca E, Candeloro M, De Tursi M, Russi I, Rutjes AW.

Cochrane Database Syst Rev. 2016 Dec 1;12:CD008500. doi: 10.1002/14651858.CD008500.pub4. Review.

19.

Secondary prevention of recurrent venous thromboembolism after initial oral anticoagulation therapy in patients with unprovoked venous thromboembolism.

Robertson L, Yeoh SE, Ramli A.

Cochrane Database Syst Rev. 2017 Dec 15;12:CD011088. doi: 10.1002/14651858.CD011088.pub2. Review.

20.

A genome-wide association study of venous thromboembolism identifies risk variants in chromosomes 1q24.2 and 9q.

Heit JA, Armasu SM, Asmann YW, Cunningham JM, Matsumoto ME, Petterson TM, De Andrade M.

J Thromb Haemost. 2012 Aug;10(8):1521-31. doi: 10.1111/j.1538-7836.2012.04810.x.

Supplemental Content

Support Center